3. Introduction
• Sharp, electric shock-like paroxysmal lancinating pain in the distribution
of one or more branches of the TN on one side
• Annual incidence 4/100,000
• 2% of pts with MS have TGN, ≈ 18% of pts with bilateral TGN have MS.
5/28/2018 ABDIER 3
4. Anatomy
• The trigeminal nerve leaves the midlateral surface of the pons and
enter Meckes cave
• The TN bas three divisions-
1 Ophthalmic (CNV1)
2 Maxillary (CN V2)
3 Mandibular (CN V3)
5/28/2018 ABDIER 4
5. Pathophysiology
• Due to ephaptic transmission in TN from large-diameter partially
demyelinated A fibers to thinly myelinated A-delta and C fibers
• Pathogenesis may be due to:
1. vascular compression of the TN at the REZ
a) most commonly (80%) by the SCA;
b) persistent primitive trigeminal artery
c) dolichoectatic basilar artery
5/28/2018 ABDIER 5
7. Evaluation and Diagnosis
1. History; diagnosis of TGN is based nearly entirely on the pt’s hx
2. Physical exam; unremarkable; minor sensory changes in the
corresponding distribution of the TN are not uncommon
3.Imaging; MRI or CT scan to exclude structural pathologies
On high resolution T2W imaging, a vascular loop is often evident
compressing the TN.
5/28/2018 ABDIER 7
8. Evalution…
• Typical TGN ; caused by blood vessel compressing the TN root
• Atypical TGN ;a unilateral, prominent constant and severe aching and
burning pain superimposed upon otherwise typical symptom.
• Pre- TGN ;Days to yrs before the first attack of TGN pain, pts
experience odd sensations of pain, such as toothache or parasthesia.
• MS related TGN ;identical to typical TGN. Bilateral TGN is more
commonly seen in people with MS.
5/28/2018 ABDIER 8
9. Differential Diagnosis
• Dental pathologies, temporomandibular joint pain, eye pain, facial
trauma and bony fractures,
• Tumor of the facial bones or the trigeminal nerve, giant cell arteritis,
Tolosa-Hunt syndrome ,
• Trigeminal autonomic cephalgias and
• Other primary headache syndromes can cause facial pain
5/28/2018 ABDIER 9
10. Management
Medical therapy for trigeminal neuralgia
Carbamazepine;It initially provides 100% pain relief for 70% of pts
Baclofen ; 2nd DOC
May be more effective if used in conjunction with low dose
carbamazepine.
5/28/2018 ABDIER 10
11. Surgical therapy for trigeminal neuralgia
Aimed at either destroying parts of nerve fibers or decompressing
the trigeminal nerve to relieve pain
Indications for surgery
Refractory to medical management, or
Side effects of medications exceed risks and drawbacks of surgery.
5/28/2018 ABDIER 11
12. Surgical options
Surgical options for TGN fall into two categories:
1. Palliative destructive procedures
2. Physiologic nondestructive MVD
5/28/2018 ABDIER 12
13. Surgical…
• Palliative destructive procedures involve controlled damage to the TN
root with the aim of pain relief
• Include radiofrequency lesioning, glycerol rhizolysis, balloon
compression rhizotomy, and stereotactic radiosurgery rhizotomy
• recurrence rate of about 50% after 3 to 5 years
• MVD surgery is associated with an approximately 80% chance of pain
freedom among carefully selected patients.
5/28/2018 ABDIER 13
14. Surgical…
• Pts > 70 yrs should seek less invasive percutaneous procedures such as
balloon compression, radiofrequency, or glycerol rhizotomy.
• Radiosurgery is also an option but the chance of pain freedom without
medications is less
• Pts <40 yrs should be carefully evaluated before intervention because
disappointing recurrence of pain
• Atypical pain associated with burning neuropathic, rather than
neuralgic pain, is not amenable to surgery
5/28/2018 ABDIER 14
15. Surgical...
• Pts who cannot undergo MVD, balloon compression rhizotomy is
recommended because it is easy to perform and immediately effective.
• If the pt harbors comorbidities that preclude the use of GA and
immediate pain relief is not a concern, radiosurgery as a reasonable
option.
5/28/2018 ABDIER 15
16. Balloon Compression
• Injures medium and large myelinated fibers while sparing
small myelinated and unmyelinated fibers.
• Particularly useful in patients with V1.TN
• Contralateral master weakness is a relative contraindication
for this technique because BC causes temporary and
permanent masseter weakness
5/28/2018 ABDIER 16
17. Balloon …
A 20-year review of percutaneous BC of the trigeminal ganglion
• David J. Skirving, M.B.B.S. , and Noel G. Dan, F.R.A.C.S.
• Department of Neurosurgery, Concord Repatriation General Hospital, University of Sydney,
Austria
• 496 pts with typical symptoms of unilateral TGN who underwent 531
PBCs
9 technical failures.
522 successful procedures, prompt pain relief ensued in all pts except
one.
Recurrence of pain was found in 95 patients (19.2%) within 5 yrs and in
158 pts (31.9%) over the entire study period.
5/28/2018 ABDIER 17
18. Surgical…
Microvascular decompression
• Recommended for pts with inadequate medical control of pain with > 5
years anticipated survival
• Relief is often long lived, persevering 10 yrs in 70%.
• Incidence of facial anesthesia is much less than with PTR,
5/28/2018 ABDIER 18
19. Surgical…
• MVD for TGN involves identification of the TN and the offending
vessel through the retrosigmoid craniectomy putting a Teflon in b/n
the two.
5/28/2018 ABDIER 19
20. Surgical…
Microvascular decompression for trigeminal neuralgia
. Robert Breeze, M.D., and Ronald J. Ignelzi, M.D.
. Division of Neurological Surgery, University of California Medical Center, San
Diego, California
✓ 51 pts with TGN underwent 52 procedures for MVD.
85% early success rate;
13% late recurrence rate was found.
60% of the patients experienced some form of
complication, but in only 23% was the complication
persistent
5/28/2018 ABDIER 20
22. Surgical…
Peripheral nerve ablation and neurectomies
Limited to pain or trigger points in territory of
supraorbital/supratrochlear, infraorbital, or inferiordental nerves.
Neurectomy may be a consideration especially for elderly patients
who are not candidates for MVD
5/28/2018 ABDIER 22
24. Mgt of surgical treatment failures
90% of recurrences are in distribution of previously involved divisions;
10% in new division, represent progression of the underlying process
5/28/2018 ABDIER 24
25. Mgt…
PTR may be repeated in pts who have a recurrence with some
preservation of facial sensation.
MVD may be performed in pts failing PTR, but the success rate may
be reduced
SRS can be repeated, using the same dose, with reported significant
reduction in pain in 89%, and complete relief in 58%
5/28/2018 ABDIER 25
26. Mgt…
Intradural retrogasserian trigeminal nerve section
• May be used as a measure of last resort in pts who have recurrent
TGN following one or more PTRs in the presence of total facial
anesthesia, or
• In pts undergoing posterior-fossa craniectomy for the purpose of
MVD when no impinging vessel can be identified
5/28/2018 ABDIER 26
27. Reference
Greenberg Handbook of neurosurgery 8th Edition
Youmans and Winn Neurological Surgery 7th Editon
Jornal of Neurosurgery
The Neurosurgical Atlas
5/28/2018 ABDIER 27
Editor's Notes
as a large sensory root
and a smaller motor root for muscles of mastication..masseter,temporalies,ptrygoids,mylohyoid, tensor tempani ,palati
The most common of the persistent fetal anastomoses (83%). Connects the cavernous carotid to the basilar artery bn AICA & SCA.
that is often poorly responsive to microvascular decompression
the character of the pain is typically unilateral, episodic, severe, stabbing,
shock-like or lancinating, and exacerbated by cutaneous stimuli such
as tactile pressure, chewing, brushing, a breeze of air, or shaving.younger patients
atypical clinical features
sensory loss
dull burning pain between paroxysms
patients who do not respond to initial medical therapy
Some believe that atypical TNG is due to vascular compression upon specific part of the TG
75% will ultimately fail medical therapy and require a procedure
100 mg PO BID, increase by 200 mg/d up to maximum of 1200mg/d divided TID
Patients with classic trigeminal neuralgia, evidence of vascular compression, shorter duration of disease, and no previous surgery respond better to all treatment options.
The patient’s symptoms should at least last 1 year with aggressive
medical intervention before surgery is considered. This philosophy is
justified since the pain may be short-lived in some patients.
This effect lasts for more than 10-20 years with a recurrence rate of 10%.
and may actually worsen after surgery.
Radiosurgery does not offer an immediate pain relief and many pts continue to require neuralgic medications for their pain
aim for balloon placement foramen ovale through a trajectory aiming towards
the plane intersecting a point 3 cm anterior to EAM and the medial aspect of the pupil when
the eye is directed forward This injury to the medium and large fibers is responsible for disruption of the ephaptic transmission of pain.
because of the ability of this percutaneous modality to preserve the corneal reflex
David J. Skirving, M.B.B.S. , and Noel G. Dan, F.R.A.C.S.
Department of Neurosurgery, Concord Repatriation General Hospital, University of Sydney, Australia
Address reprint requests to: Noel Dan, F.R.A.C.S., Specialist Medical Centre, 235 New South Head Road, Edgecliff NSW 2027, Australia. email: davidskirving@hotmail.com.
Journal of Neurosurgery
Vol. 94: , Issue. 6, : Pages. 913-917
(Issue publication date: June 2001)
https://doi.org/10.3171/jns.2001.94.6.0913
Object. The aim of this study was to investigate outcomes and complication rates associated with percutaneous balloon compression (PBC) of the trigeminal ganglion over a long follow-up period.
Methods. This retrospective review was conducted in 496 patients with typical symptoms of unilateral trigeminal neuralgia who underwent 531 PBCs of the trigeminal ganglion between 1980 and 1999. The mean length of follow up was 10.7 years. The treatment used was a modification of that first described by Mullan and Lichtor in 1983.
There were nine technical failures. Of the 522 successful procedures, prompt pain relief ensued in all patients except one. Recurrence of pain was found in 95 patients (19.2%) within 5 years and in 158 patients (31.9%) over the entire study period. Symptomatic dysesthesias occurred in 19 patients (3.8%), but corneal anesthesia and anesthesia dolorosa did not.
Microvascular decompression for trigeminal neuralgia
Results with special reference to the late recurrence rate
Robert Breeze, M.D., and Ronald J. Ignelzi, M.D.
Division of Neurological Surgery, University of California Medical Center, San Diego, California
Address for Dr. Breeze: Department of Neurological Surgery, Los Angeles County/University of Southern California Medical Center, Los Angeles, California.
Address reprint requests to: Ronald J. Ignelzi, M.D., Division of Neurological Surgery (H-893), University Hospital, 225 Dickinson Street, San Diego, California 92103.
Journal of Neurosurgery
Vol. 57: , Issue. 4, : Pages. 487-490
(Issue publication date: October 1982)
https://doi.org/10.3171/jns.1982.57.4.0487@col.2017.127.issue-Collection
✓ Fifty-one consecutive patients with trigeminal neuralgia underwent 52 procedures for microvascular decompression of the trigeminal nerve root entry zone. There was an 85% early success rate; however, after a longer follow-up period, a 13% late recurrence rate was found. In all, 60% of the patients experienced some form of complication, but in only 23% was the complication